| Troy Michael Robinson, PA-C | |
|
351 Winchester St, Keene, NH 03431-3930 | |
| (603) 352-3406 | |
| Not Available |
| Full Name | Troy Michael Robinson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 351 Winchester St, Keene, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023619269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 1658 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foundation Medical Partners Inc | 9436140456 | 280 |
News Archive
The immune system may open the door to recurrent urinary tract infections (UTIs) by overdoing its response to an initial infection, researchers at Washington University School of Medicine in St. Louis have found.Researchers showed in mice that severe inflammatory responses to an initial UTI cause bladder damage and allow infection to persist longer. After one to two weeks of infection, the bladder wall undergoes additional changes that leave mice more vulnerable to later infection. Suppressing the immune system during initial infection decreases these vulnerabilities, they report Aug. 12 in PLoS Pathogens.
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
KHN examines new penalties hospitals face under the health law. Meanwhile, Medpage Today reports on the American College of Physicians' new recommendations on government rules about doctors' interactions with patients.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.
Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc., which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Troy Michael Robinson, PA-C 111 New Hampshire Ave Ste 2, Portsmouth, NH 03801-2864 Ph: (603) 319-4490 | Troy Michael Robinson, PA-C 351 Winchester St, Keene, NH 03431-3930 Ph: (603) 352-3406 |
News Archive
The immune system may open the door to recurrent urinary tract infections (UTIs) by overdoing its response to an initial infection, researchers at Washington University School of Medicine in St. Louis have found.Researchers showed in mice that severe inflammatory responses to an initial UTI cause bladder damage and allow infection to persist longer. After one to two weeks of infection, the bladder wall undergoes additional changes that leave mice more vulnerable to later infection. Suppressing the immune system during initial infection decreases these vulnerabilities, they report Aug. 12 in PLoS Pathogens.
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
KHN examines new penalties hospitals face under the health law. Meanwhile, Medpage Today reports on the American College of Physicians' new recommendations on government rules about doctors' interactions with patients.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT's human embryonic stem cell (hESC)-derived retinal pigment epithelial (RPE) cells for designation as an orphan medicinal product for the treatment of Stargardt's disease.
Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc., which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories.
› Verified 8 days ago
Kristie N La Monica, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5496 | |
Mr. Joseph Henry Cameron, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 580-90 Court Street, Keene, NH 03431 Phone: 603-354-5400 | |
Jason Davis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 978-407-3044 | |
Russell Arpin, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 590 Court Street, Dartmouth Hitchcock - Orthopaedics, Keene, NH 03431 Phone: 603-354-5400 | |
Jaye L Morgan, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Patricia Morrison, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-6515 |